Arax Advisory Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.2K | Hold |
649
| – | – | ﹤0.01% | 1026 |
|
|
2025
Q1 | $83.1K | Sell |
649
-4
| -0.6% | -$512 | 0.01% | 779 |
|
|
2024
Q4 | $86.4K | Hold |
653
| – | – | 0.01% | 722 |
|
|
2024
Q3 | $95.1K | Buy |
653
+101
| +18% | +$14.7K | 0.01% | 504 |
|
|
2024
Q2 | $75.8K | Buy |
552
+480
| +667% | +$65.9K | 0.01% | 534 |
|
|
2024
Q1 | $9.9K | Buy |
72
+4
| +6% | +$550 | ﹤0.01% | 779 |
|
|
2023
Q4 | $9.25K | Hold |
68
| – | – | ﹤0.01% | 771 |
|
|
2023
Q3 | $8.33K | Hold |
68
| – | – | ﹤0.01% | 766 |
|
|
2023
Q2 | $8.65K | Hold |
68
| – | – | ﹤0.01% | 738 |
|
|
2023
Q1 | $8.8K | Hold |
68
| – | – | ﹤0.01% | 713 |
|
|
2022
Q4 | $8.94K | Sell |
68
-72
| -51% | -$9.46K | ﹤0.01% | 665 |
|
|
2022
Q3 | $16K | Hold |
140
| – | – | ﹤0.01% | 596 |
|
|
2022
Q2 | $16K | Hold |
140
| – | – | ﹤0.01% | 585 |
|
|
2022
Q1 | $18K | Hold |
140
| – | – | ﹤0.01% | 584 |
|
|
2021
Q4 | $21K | Buy |
+140
| New | +$21K | ﹤0.01% | 564 |
|
|
2020
Q4 | $11K | Sell |
70
-71
| -50% | -$11.2K | ﹤0.01% | 555 |
|
|
2020
Q3 | $19K | Buy |
+141
| New | +$19K | ﹤0.01% | 477 |
|
|
2020
Q1 | – | Sell |
-182
| Closed | -$22K | – | 697 |
|
|
2019
Q4 | $22K | Hold |
182
| – | – | 0.01% | 410 |
|
|
2019
Q3 | $18K | Sell |
182
-6
| -3% | -$593 | 0.01% | 416 |
|
|
2019
Q2 | $20K | Buy |
+188
| New | +$20K | 0.01% | 410 |
|
|
2018
Q4 | $17K | Hold |
181
| – | – | 0.01% | 389 |
|
|
2018
Q3 | $22K | Buy |
+181
| New | +$22K | 0.01% | 391 |
|